ALSPW Fundamental Analysis - SPINEWAY

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALSPW. ALSPW was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While ALSPW seems to be doing ok healthwise, there are quite some concerns on its profitability. ALSPW is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALSPW had negative earnings in the past year.

ALSPW had a positive operating cash flow in the past year.

ALSPW had negative earnings in each of the past 5 years.

ALSPW had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ALSPW has a worse Return On Assets (-6.29%) than 71.43% of its industry peers.

Looking at the Return On Equity, with a value of -7.96%, ALSPW is doing worse than 69.84% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-6.29%
ROE	-7.96%
ROIC	N/A

ROA(3y)-16.26%

ROA(5y)-30.05%

ROE(3y)-21.45%

ROE(5y)-42.44%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALSPW has a better Gross Margin (71.33%) than 84.13% of its industry peers.

ALSPW's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for ALSPW so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	71.33%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.32%

GM growth 5Y16.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALSPW has more shares outstanding than it did 1 year ago.

ALSPW has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ALSPW has an improved debt to assets ratio.

2.2 Solvency

ALSPW has an Altman-Z score of 1.37. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.37, ALSPW is doing worse than 68.25% of the companies in the same industry.

A Debt/Equity ratio of 0.06 indicates that ALSPW is not too dependend on debt financing.

The Debt to Equity ratio of ALSPW (0.06) is better than 84.13% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Altman-Z	1.37

ROIC/WACCN/A

WACC7.16%

2.3 Liquidity

ALSPW has a Current Ratio of 3.19. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 3.19, ALSPW belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.

A Quick Ratio of 2.04 indicates that ALSPW has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 2.04, ALSPW belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.19
Quick Ratio	2.04

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.85% over the past year.

Looking at the last year, ALSPW shows a decrease in Revenue. The Revenue has decreased by -5.46% in the last year.

The Revenue has been growing by 18.95% on average over the past years. This is quite good.

EPS 1Y (TTM)99.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%95.92%

Revenue 1Y (TTM)-5.46%

Revenue growth 3Y40.7%

Revenue growth 5Y18.95%

Sales Q2Q%-14.72%

3.2 Future

The Earnings Per Share is expected to decrease by -41.47% on average over the next years. This is quite bad

The Revenue is expected to grow by 40.08% on average over the next years. This is a very strong growth

EPS Next Y-100.08%

EPS Next 2Y-41.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2Y40.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALSPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPW. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

ALSPW's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALSPW is cheaper than 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.61

4.3 Compensation for Growth

A cheap valuation may be justified as ALSPW's earnings are expected to decrease with -41.47% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-41.47%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALSPW does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SPINEWAY

EPA:ALSPW (12/5/2025, 7:00:00 PM)

0.153

+0 (+1.32%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)10-14 2025-10-14

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap5.44M

Revenue(TTM)10.99M

Net Income(TTM)-1.90M

Analysts86.67

Price Target0.28 (83.01%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-25%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)44.44%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.49
P/FCF	N/A
P/OCF	9.36
P/B	0.23
P/tB	0.38
EV/EBITDA	2.61

EPS(TTM)-0.05

EYN/A

EPS(NY)-0.08

Fwd EYN/A

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)0.02

OCFY10.68%

SpS0.31

BVpS0.67

TBVpS0.41

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.29%
ROE	-7.96%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	71.33%
FCFM	N/A

ROA(3y)-16.26%

ROA(5y)-30.05%

ROE(3y)-21.45%

ROE(5y)-42.44%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.32%

GM growth 5Y16.07%

F-Score6

Asset Turnover0.36

Health

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Debt/EBITDA	1.36
Cap/Depr	118.69%
Cap/Sales	12.83%
Interest Coverage	N/A
Cash Conversion	51.42%
Profit Quality	N/A
Current Ratio	3.19
Quick Ratio	2.04
Altman-Z	1.37

F-Score6

WACC7.16%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)99.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%95.92%

EPS Next Y-100.08%

EPS Next 2Y-41.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-5.46%

Revenue growth 3Y40.7%

Revenue growth 5Y18.95%

Sales Q2Q%-14.72%

Revenue Next YearN/A

Revenue Next 2Y40.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y97.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y94.45%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y121.03%

OCF growth 3YN/A

OCF growth 5YN/A

SPINEWAY / ALSPW.PA FAQ

Can you provide the ChartMill fundamental rating for SPINEWAY?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPW.PA.

What is the valuation status for ALSPW stock?

ChartMill assigns a valuation rating of 1 / 10 to SPINEWAY (ALSPW.PA). This can be considered as Overvalued.

What is the profitability of ALSPW stock?

SPINEWAY (ALSPW.PA) has a profitability rating of 2 / 10.

What is the earnings growth outlook for SPINEWAY?

The Earnings per Share (EPS) of SPINEWAY (ALSPW.PA) is expected to decline by -100.08% in the next year.

Can you provide the dividend sustainability for ALSPW stock?

The dividend rating of SPINEWAY (ALSPW.PA) is 0 / 10 and the dividend payout ratio is 0%.

SPINEWAY (ALSPW.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SPINEWAY / ALSPW.PA FAQ

Can you provide the ChartMill fundamental rating for SPINEWAY?

What is the valuation status for ALSPW stock?

What is the profitability of ALSPW stock?

What is the earnings growth outlook for SPINEWAY?

Can you provide the dividend sustainability for ALSPW stock?